Reducing Uncertainty: Predictors of Stopping Chemotherapy Early and Shortened Survival Time in Platinum Resistant/Refractory Ovarian Cancer-The GCIG Symptom Benefit Study.

Saved in:
Bibliographic Details
Title: Reducing Uncertainty: Predictors of Stopping Chemotherapy Early and Shortened Survival Time in Platinum Resistant/Refractory Ovarian Cancer-The GCIG Symptom Benefit Study.
Authors: Roncolato FT; NHMRC Clinical Trials Centre, University of Sydney, Sydney, Australia felicia.roncolato@ctc.usyd.edu.au.; Australia New Zealand Gynaecological Oncology Group (ANZGOG), New South Wales, Australia.; Macarthur Cancer Therapy Centre, New South Wales, Australia., Joly F; Centre Francois Baclesse, Caen, France., O'Connell R; NHMRC Clinical Trials Centre, University of Sydney, Sydney, Australia., Lanceley A; University College London, London, England., Hilpert F; Klinik fur Gynakologie und Geburtshilfe, UKSH, Kiel, Germany., Buizen L; NHMRC Clinical Trials Centre, University of Sydney, Sydney, Australia., Okamoto A; The Jikei University School of Medicine, Tokyo, Japan., Aotani E; Kitasato Academic Research Organization, Tokyo, Japan., Pignata S; Istituto Nazionale per lo Studio e la Cura dei Tumori - Fondazione G. Pascale, IRCCS, Napoli (MITO), Italy., Donnellan P; Cancer Trials Ireland, Galway University Hospital, Galway, Ireland., Oza A; Princess Margaret Cancer Centre, University of Toronto, Toronto, Ontario, Canada., Avall-Lundqvist E; Department of Oncology, Linköping University, Linköping, Sweden.; Department of Clinical and Experimental Medicine, Linköping University, Linköping, Sweden.; Karolinska Institutet, Stockholm, Sweden., Berek JS; Stanford Comprehensive Cancer Institute, Stanford, California, USA., Heitz F; AGO Study group and Department of Gynecology & Gynecologic Oncology, Kliniken Essen Mitte (KEM), Essen, Germany., Feeney A; Cancer Research UK & UCL Cancer Trials Centre, London, England., Berton-Rigaud D; ICO Centre René Gauducheau, Saint Herblain, France., Stockler MR; NHMRC Clinical Trials Centre, University of Sydney, Sydney, Australia.; Australia New Zealand Gynaecological Oncology Group (ANZGOG), New South Wales, Australia., King M; Australia New Zealand Gynaecological Oncology Group (ANZGOG), New South Wales, Australia.; Psycho-oncology Research Group (PoCoG), School of Psychology and Sydney Medical School, University of Sydney, Sydney, Australia., Friedlander M; Australia New Zealand Gynaecological Oncology Group (ANZGOG), New South Wales, Australia.; Prince of Wales Hospital, Sydney, Australia.
Corporate Authors: GCIG Symptom Benefit group
Source: The oncologist [Oncologist] 2017 Sep; Vol. 22 (9), pp. 1117-1124. Date of Electronic Publication: 2017 Jun 08.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Oxford University Press Country of Publication: England NLM ID: 9607837 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1549-490X (Electronic) Linking ISSN: 10837159 NLM ISO Abbreviation: Oncologist Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1549-490X
DOI:10.1634/theoncologist.2017-0047